Synonyms: compound 2 [PMID: 23124563] | KRP-203 | KRP203
Compound class:
Synthetic organic
Comment: Mocravimod (KRP203) is a sphingosine 1-phosphate receptor type 1 (S1P1R) agonist with immunomodulatory potential [6]. Structurally mocravimod is a highly modified analogue of the approved multiple sclerosis drug fingolimod. Like fingolimod it is a prodrug that is phosphorylated in vivo by sphingosine kinase 2 (SPHK2), with mocravimod-phosphate (+KRP203-phosphate) being the active entity.
|
|
Bioactivity Comments |
There is evidence to support mocravimod's action as a partial (low potency) agonist at the S1P3R [4]. The selectivity for S1P1R over S1P3R is proposed to reduce S1P3R-driven bradycardia that is observed as a side effect with the non-selective S1PR modulator fingolimod (FTY720) [5]. |